1. Medtech Insight

M&A Analysis – Deals March On In Big Month For Boston Scientific

 
• By Catherine Longworth

Medtech Insight recorded 17 merger or acquisition deals in March, a rise from the nine deals recorded last month and in the same period last year. It was a busy month for Boston Scientific, which racked up two acquisitions, paying $460m for urology device maker NxThera and an undisclosed price for endoscopy firm EMcision.

Merging Business Network-Business leaders in global agreement

Medtech M&A activity resumed pace in March after a quiet February. Medtech Insight recorded 17 deals for the month, a rise from the nine deals announced in February and also in the same period last year. However, March did not have the biggest deal volume this year to date, being on par with January 2018. (See Figure 1.)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business